The two companies’ combined portfolios will offer medication management solutions across the continuum of care.
“BD’s acquisition of CareFusion allows us to align our highly complementary technologies and products to address unmet needs in the growing $20 billion global medication management industry, which leverages BD’s worldwide infrastructure,” said Vincent A. Forlenza, BD’s chairman, CEO and president. “It accelerates BD’s transition from a product-focused company to a customer-centric provider of innovative healthcare solutions with leading scale across the medication management value chain and expanded solutions for patient safety.”
The deal is pending regulatory and CareFusion shareholder approval, but is expected to close in the first half of 2015.
More articles on CareFusion:
CareFusion launches smaller size ChloraPrep applicator for infection prevention
CareFusion Foundation Awards $500k to 11 Organizations for Medication Safety Programs
Healthcare Informatics Ranks 100 Top Health IT Companies by Revenue
